Cullinan Oncology LLC (CGEM) stock news · $830.3M cap
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
This CGEM news page leads with what Cullinan Oncology LLC filed — not a scraped headline mill.
No cached 8-K sentence for CGEM yet. We will not pad this page with generic market recap.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $111.2M. CGEM currently screens at market cap $830.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CGEM stock page; for the tape open the quote page.
CGEM stock news FAQ
What is CGEM's latest net income?
Latest cached Cullinan Oncology LLC (CGEM) net income was $111.2M. Statements: https://lician.com/financials/cgem
What is CGEM's market cap?
Cullinan Oncology LLC (CGEM) market cap is $830.3M on the latest cached fundamentals snapshot.
What kind of company is CGEM?
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Where is CGEM stock news listed?
Cached stock news for Cullinan Oncology LLC (CGEM) is listed at https://lician.com/news/cgem. Filings: https://lician.com/sec/cgem
Not investment advice.